ONTOLOGY REPORT - ANNOTATIONS
|
|||||||||||||
endothelin signaling pathway
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Evidence | Chr | Start | Stop | Reference | Source | |||
| G | ADCY1 | adenylate cyclase 1 (brain) |
|
EXP | 7 | 45,614,125 | 45,762,715 | RGD:6484113 | PID | ||
| G | ADCY2 | adenylate cyclase 2 (brain) |
|
EXP | 5 | 7,396,343 | 7,830,194 | RGD:6484113 | PID | ||
| G | ADCY3 | adenylate cyclase 3 |
|
EXP | 2 | 25,042,038 | 25,142,055 | RGD:6484113 | PID | ||
| G | ADCY4 | adenylate cyclase 4 |
|
EXP | 14 | 24,787,555 | 24,804,277 | RGD:6484113 | PID | ||
| G | ADCY5 | adenylate cyclase 5 |
|
EXP | 3 | 123,001,143 | 123,167,392 | RGD:6484113 | PID | ||
| G | ADCY6 | adenylate cyclase 6 |
|
EXP | 12 | 49,159,975 | 49,182,820 | RGD:6484113 | PID | ||
| G | ADCY7 | adenylate cyclase 7 |
|
EXP | 16 | 50,321,823 | 50,352,043 | RGD:6484113 | PID | ||
| G | ADCY8 | adenylate cyclase 8 (brain) |
|
EXP | 8 | 131,792,547 | 132,052,835 | RGD:6484113 | PID | ||
| G | ADCY9 | adenylate cyclase 9 |
|
EXP | 16 | 4,012,650 | 4,166,186 | RGD:6484113 | PID | ||
| G | AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
|
EXP | 14 | 105,235,686 | 105,262,080 | RGD:6484113 | PID | ||
| G | BCAR1 | breast cancer anti-estrogen resistance 1 |
|
EXP | 16 | 75,262,928 | 75,301,951 | RGD:6484113 | PID | ||
| G | CDC42 | cell division cycle 42 |
|
EXP | 1 | 22,379,120 | 22,419,436 | RGD:6484113 | PID | ||
| G | COL1A2 | collagen, type I, alpha 2 |
|
EXP | 7 | 94,023,873 | 94,060,544 | RGD:6484113 | PID | ||
| G | COL3A1 | collagen, type III, alpha 1 |
|
EXP | 2 | 189,839,099 | 189,877,472 | RGD:6484113 | PID | ||
| G | CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) |
|
EXP | 17 | 1,324,647 | 1,359,561 | RGD:6484113 | PID | ||
| G | CYSLTR1 | cysteinyl leukotriene receptor 1 |
|
EXP | X | 77,528,130 | 77,583,087 | RGD:6484113 | PID | ||
| G | CYSLTR2 | cysteinyl leukotriene receptor 2 |
|
EXP | 13 | 49,280,951 | 49,283,498 | RGD:6484113 | PID | ||
| G | ECE1 | endothelin converting enzyme 1 |
|
ISS | 1 | 21,543,740 | 21,672,034 | RGD:1581735 | RGD | ||
| G | EDN1 | endothelin 1 |
|
TAS | 6 | 12,290,529 | 12,297,427 | RGD:1580323 | RGD | ||
| G | EDN1 | endothelin 1 |
|
EXP | 6 | 12,290,529 | 12,297,427 | RGD:6484113 | PID | ||
| G | EDN2 | endothelin 2 |
|
EXP | 1 | 41,944,446 | 41,950,344 | RGD:6484113 | PID | ||
| G | EDN3 | endothelin 3 |
|
EXP | 20 | 57,875,499 | 57,901,047 | RGD:6484113 | PID | ||
| G | EDNRA | endothelin receptor type A |
|
ISS | 4 | 148,402,069 | 148,466,106 | RGD:4892591 | RGD | ||
| G | EDNRA | endothelin receptor type A |
|
EXP | 4 | 148,402,069 | 148,466,106 | RGD:6484113 | PID | ||
| G | EDNRB | endothelin receptor type B |
|
ISS | 13 13 |
78,469,616 78,513,393 |
78,549,664 78,549,674 |
RGD:4892591 | RGD | ||
| G | EDNRB | endothelin receptor type B |
|
EXP | 13 13 |
78,469,616 78,513,393 |
78,549,664 78,549,674 |
RGD:6484113 | PID | ||
| G | FOS | FBJ murine osteosarcoma viral oncogene homolog |
|
EXP | 14 | 75,745,481 | 75,748,937 | RGD:6484113 | PID | ||
| G | GNA11 | guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
|
EXP | 19 | 3,094,408 | 3,121,468 | RGD:6484113 | PID | ||
| G | GNA12 | guanine nucleotide binding protein (G protein) alpha 12 |
|
EXP | 7 | 2,767,739 | 2,883,959 | RGD:6484113 | PID | ||
| G | GNA14 | guanine nucleotide binding protein (G protein), alpha 14 |
|
EXP | 9 | 80,037,995 | 80,263,232 | RGD:6484113 | PID | ||
| G | GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) |
|
EXP | 19 | 3,136,191 | 3,163,766 | RGD:6484113 | PID | ||
| G | GNAI1 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
EXP | 7 | 79,764,140 | 79,848,725 | RGD:6484113 | PID | ||
| G | GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
EXP | 3 | 50,273,647 | 50,296,786 | RGD:6484113 | PID | ||
| G | GNAI3 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
|
EXP | 1 | 110,091,186 | 110,138,465 | RGD:6484113 | PID | ||
| G | GNAL | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type |
|
EXP | 18 | 11,689,014 | 11,885,684 | RGD:6484113 | PID | ||
| G | GNAO1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
|
EXP | 16 | 56,225,251 | 56,391,356 | RGD:6484113 | PID | ||
| G | GNAQ | guanine nucleotide binding protein (G protein), q polypeptide |
|
EXP | 9 | 80,335,189 | 80,646,219 | RGD:6484113 | PID | ||
| G | GNAZ | guanine nucleotide binding protein (G protein), alpha z polypeptide |
|
EXP | 22 | 23,412,669 | 23,467,221 | RGD:6484113 | PID | ||
| G | HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
|
EXP | 11 | 532,242 | 535,550 | RGD:6484113 | PID | ||
| G | JAK2 | Janus kinase 2 |
|
EXP | 9 | 4,985,245 | 5,128,183 | RGD:6484113 | PID | ||
| G | JUN | jun proto-oncogene |
|
EXP | 1 | 59,246,463 | 59,249,785 | RGD:6484113 | PID | ||
| G | MAP2K1 | mitogen-activated protein kinase kinase 1 |
|
EXP | 15 | 66,679,211 | 66,783,882 | RGD:6484113 | PID | ||
| G | MAP2K2 | mitogen-activated protein kinase kinase 2 |
|
EXP | 19 | 4,090,319 | 4,124,126 | RGD:6484113 | PID | ||
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
EXP | 22 | 22,113,946 | 22,221,970 | RGD:6484113 | PID | ||
| G | MAPK14 | mitogen-activated protein kinase 14 |
|
EXP | 6 | 35,995,454 | 36,079,013 | RGD:6484113 | PID | ||
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
EXP | 16 | 30,125,426 | 30,134,630 | RGD:6484113 | PID | ||
| G | MAPK8 | mitogen-activated protein kinase 8 |
|
EXP | 10 | 49,609,687 | 49,643,183 | RGD:6484113 | PID | ||
| G | MMP1 | matrix metallopeptidase 1 (interstitial collagenase) |
|
EXP | 11 | 102,660,641 | 102,668,966 | RGD:6484113 | PID | ||
| G | NFATC3 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
|
ISS | 16 | 68,119,269 | 68,263,162 | RGD:1581961 | RGD | ||
| G | NOS2 | nitric oxide synthase 2, inducible |
|
ISS | 17 | 26,083,792 | 26,127,555 | RGD:1582119 | RGD | ||
| G | PLA2G4A | phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
EXP | 1 | 186,798,032 | 186,958,113 | RGD:6484113 | PID | ||
| G | PLCB1 | phospholipase C, beta 1 (phosphoinositide-specific) |
|
EXP | 20 | 8,113,296 | 8,865,547 | RGD:6484113 | PID | ||
| G | PLCB2 | phospholipase C, beta 2 |
|
EXP | 15 | 40,580,098 | 40,600,174 | RGD:6484113 | PID | ||
| G | PLCB3 | phospholipase C, beta 3 (phosphatidylinositol-specific) |
|
EXP | 11 | 64,018,995 | 64,036,924 | RGD:6484113 | PID | ||
| G | PRKCA | protein kinase C, alpha |
|
EXP | 17 | 64,298,926 | 64,806,862 | RGD:6484113 | PID | ||
| G | PRKCD | protein kinase C, delta |
|
EXP | 3 | 53,195,223 | 53,226,733 | RGD:6484113 | PID | ||
| G | PRKCE | protein kinase C, epsilon |
|
EXP | 2 | 45,879,043 | 46,415,129 | RGD:6484113 | PID | ||
| G | PRKCG | protein kinase C, gamma |
|
EXP | 19 | 54,385,467 | 54,410,901 | RGD:6484113 | PID | ||
| G | PRKCH | protein kinase C, eta |
|
EXP | 14 | 61,788,515 | 62,017,698 | RGD:6484113 | PID | ||
| G | PRKCQ | protein kinase C, theta |
|
EXP | 10 | 6,469,105 | 6,622,254 | RGD:6484113 | PID | ||
| G | PTK2B | protein tyrosine kinase 2 beta |
|
EXP | 8 | 27,168,999 | 27,316,908 | RGD:6484113 | PID | ||
| G | RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
|
EXP | 7 | 6,414,126 | 6,443,598 | RGD:6484113 | PID | ||
| G | RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 |
|
EXP | 3 | 12,625,100 | 12,705,700 | RGD:6484113 | PID | ||
| G | RHOA | ras homolog family member A |
|
EXP | 3 | 49,396,578 | 49,449,526 | RGD:6484113 | PID | ||
| G | SLC9A1 | solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
|
EXP | 1 | 27,425,300 | 27,481,621 | RGD:6484113 | PID | ||
| G | SLC9A3 | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 |
|
EXP | 5 | 473,334 | 524,549 | RGD:6484113 | PID | ||
| G | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
EXP | 20 | 35,973,088 | 36,033,821 | RGD:6484113 | PID | ||
| G | TRPC6 | transient receptor potential cation channel, subfamily C, member 6 |
|
EXP | 11 | 101,322,295 | 101,454,659 | RGD:6484113 | PID | ||
Term paths to the root
|
| |||||||||||||||||||||




browse the term